Home
Conditions
Hemorrhagic Disorders

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,583 public trials 830 recruiting studies

Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Recruiting

The Investigate Efficacy and Safety Evaluation of Bortezomib in Patients With Relapsed/Refractory Immune Thrombocytopenia

NCT05599880

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations: Seoul National University Bundang Hospital Guri-si, South Korea

Seoul National University Hospital Seoul, South Korea

SMG-SNU Boramae Medical Center Seoul, South Korea

Seoul National University Hospital Seoul, South Korea

View Trial Details

Recruiting

Sepsis-associated Thrombocytopenia and Platelet Transfusion （STAPT）

NCT07230067

Conditions: Cardiovascular Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Nanfang Hospital， Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

A Study to Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

NCT07297329

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Beijing Chaoyang Hospital affiliated to Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Bortezomib, Isatuximab, Cyclophosphamide and Dexamethasone Induction in Transplant-Eligible Multiple Myeloma Patients With Renal Insufficiency

NCT04240054

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Female Urogenital Diseases, +19 more
Locations: Froedtert Hospital & the Medical College of Wisconsin Milwaukee, Wisconsin, United States

View Trial Details

Recruiting

DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics

NCT06296368

Conditions: Blood Cancers, Blood Protein Disorders, Cardiovascular Diseases, +19 more
Locations: Lineberger Comphrehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States

View Trial Details

Recruiting

Clinical Study of O&D-001 Injection in the Treatment of Relapsed or Refractory Multiple Myeloma

NCT07369895

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Recruiting

Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)

NCT07362238

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: Chinese Academy of Medical Science and Blood Disease Hospital Tianjin, China

View Trial Details

Recruiting

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

NCT07362225

Conditions: Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Agnogenic Myeloid Metaplasia, +78 more
Locations: MPN Research Foundation Chicago, Illinois, United States

Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Recruiting

Anti-CD38 Monoclonal Antibody Combined With Rituximab in the Management of Primary Immune Thrombocytopenia (ITP)

NCT07362199

Conditions: Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations: Chinese Academy of Medical Science and Blood Disease Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Recruiting

Vasculitis Pregnancy Registry

NCT02593565

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Aortic Arch Syndromes, Aortic Diseases, +67 more
Locations: University of South Florida Data Management and Coordinating Center Tampa, Florida, United States

View Trial Details

Hemorrhagic Disorders

Hemorrhagic Disorders trial results

Related conditions